Related Experiment Video
Updated: Mar 18, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Transforming Big Data into Cancer-Relevant Insight: An Initial, Multi-Tier Approach to Assess Reproducibility and
Abstract:
The Cancer Target Discovery and Development (CTD(2)) Network was established to accelerate the transformation of "Big Data" into novel pharmacologic targets, lead compounds, and biomarkers for rapid translation into improved patient outcomes. It rapidly became clear in this collaborative network that a key central issue was to define what constitutes sufficient computational or experimental evidence to support a biologically or clinically relevant finding. This article represents a first attempt to delineate the challenges of supporting and confirming discoveries arising from the systematic analysis of large-scale data resources in a collaborative work environment and to provide a framework that would begin a community discussion to resolve these challenges. The Network implemented a multi-tier framework designed to substantiate the biological and biomedical relevance as well as the reproducibility of data and insights resulting from its collaborative activities. The same approach can be used by the broad scientific community to drive development of novel therapeutic and biomarker strategies for cancer. Mol Cancer Res; 14(8); 675-82. ©2016 AACR.
Insights
The Cancer Target Discovery and Development (CTD(2)) Network developed a framework to validate big data findings for cancer drug discovery. This approach ensures reliable evidence for novel therapeutic and biomarker strategies.
Area of Science:
- Oncology
- Bioinformatics
- Translational Medicine
Background:
- The Cancer Target Discovery and Development (CTD(2)) Network aims to translate big data into cancer therapeutics.
- A key challenge identified was defining sufficient evidence for biological and clinical findings.
Purpose of the Study:
- To address the need for robust validation of discoveries from large-scale data analysis.
- To propose a framework for substantiating the relevance and reproducibility of collaborative research findings.
Main Methods:
- The CTD(2) Network implemented a multi-tier framework.
- This framework was designed to evaluate biological and biomedical relevance.
- Reproducibility of data and insights was a key consideration.
Main Results:
- A framework was established to support and confirm discoveries from big data analysis.
- The framework aims to enhance the reliability of novel pharmacologic targets, lead compounds, and biomarkers.
- The approach facilitates community discussion on validating research findings.
Conclusions:
- The proposed multi-tier framework can guide the scientific community in validating cancer research.
- It supports the development of novel therapeutic and biomarker strategies for cancer treatment.
- This systematic approach is crucial for translating big data into improved patient outcomes.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

